Nivashnee Naicker

Durban, ZN, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.

Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.

Journal: International journal of STD & AIDS

Published: June 14, 2026

Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.

Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 12, 2026

Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression.

Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression.

Journal: PLoS pathogens

Published: December 27, 2025

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.

Journal: EClinicalMedicine

Published: July 19, 2024

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Journal: PLOS global public health

Published: June 02, 2024

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.

Journal: Vaccine

Published: February 19, 2024

High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.

High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.

Journal: Sexually transmitted infections

Published: January 31, 2024

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Journal: PLoS medicine

Published: December 12, 2023

Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.

Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.

Journal: International journal of STD & AIDS

Published: September 26, 2023

High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.

High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.

Journal: PloS one

Published: August 08, 2023

Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa.

Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa.

Journal: Annals of epidemiology

Published: December 01, 2022

Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.

Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 02, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026